PMDA drug package insert
テルミサルタン錠20mg「TCK」
PMDA Prescription drug · 辰巳化学株式会社 · package insert Sep 9, 2025
Key facts
| Brand names | テルミサルタン錠20mg「TCK」, テルミサルタン錠40mg「TCK」, テルミサルタン錠80mg「TCK」 |
|---|---|
| Nonproprietary names | テルミサルタン |
| Companies | 製造販売元／辰巳化学株式会社, 販売元／株式会社フェルゼンファーマ |
| Product type | Prescription drug |
| Therapeutic category | 胆汁排泄型持続性AT1受容体ブロッカー |
| Therapeutic category codes | 872149 |
| YJ codes | 2149042F1092, 2149042F2099, 2149042F3095 |
| Approval numbers | 22900AMX00270000, 22900AMX00271000, 22900AMX00272000 |
| Package insert edition | 第3版 |
| Package insert date | Sep 9, 2025 |
| PMDA document key | 400278_2149042F1092_2 |
| PMDA company code | 400278 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: